SCOOP in @rollingstone.com 👇 CDC has set aside new $1.6M for controversial hepatitis B vax clinical trial in Guinea-Bissau, halted earlier amid uproar over medical ethics. CDC director's office resurrected it, taking $$ from global health security funds: www.rollingstone.com/politics/pol...
CDC Is Moving Forward With a Previously Shelved Controversial Hepatitis B Vaccine Study
“It’s a wholly unethical trial, and it shouldn’t be allowed,” says Dr. Paul Offit of Guinea-Bissau study
rollingstone.com